Friday, September 30, 2016

Eisai Announces FDA Approval of Fycompa (perampanel) Oral Suspension

›
In continuation of my update on  Fycompa Eisai Inc.  announced that the U.S. Food and Drug Administration (FDA) has approved  ...
Thursday, September 29, 2016

Brintellix (vortioxetine) Renamed Trintellix (vortioxetine) in U.S. to Avoid Name Confusion

›
In continuation of my update on  vortioxetine Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceu...
Wednesday, September 28, 2016

New drug against nerve agents in sight

›
A model of how sarin and HI-6 are positioned in the protein acetylcholinesterase just before HI-6 removes sarin and restores the functi...
Tuesday, September 27, 2016

Experimental Alzheimer's drug reverses genetic changes thought to spur the disease

›
After treatment with riluzole, the brains of old rats showed more of a transporter molecule that removes excess glutamate, (green fluo...
Monday, September 26, 2016

Screening method uncovers drugs that may combat deadly antibiotic-resistant bacteria

›
In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often...
Friday, September 23, 2016

New drug more effective in treating atrial fibrillation

›
Vernakalant, a new drug for treating recent-onset atrial fibrillation, has proved to be considerably more effective than Ibutilide, an est...
Thursday, September 22, 2016

Expand prescribing of buprenorphine for opioid abuse? Experts weigh pros and cons....

›
In continuation of my update on  Buprenorphine Buprenorphine  is a critical part of treatment for the growing epidemic of opioid abuse--...
Tuesday, September 20, 2016

Ibrutinib: Indication of added benefit in one of three therapeutic indications...

›
In continuation of my update on Ibrutinib Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the tre...
Monday, September 19, 2016

Current cancer drug discovery method flawed, study suggests: Researchers develop new approach to assess drug sensitivity in cells ..

›
The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers report May 2 in  ...
1 comment:
Friday, September 16, 2016

FDA Approves Bayer's Gadavist (gadobutrol) Injection for use with Magnetic Resonance Angiography of Supra-Aortic Arteries

›
Bayer announced  that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic ...
Tuesday, September 13, 2016

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

›
In continuation of my update on oxycodone Collegium Pharmaceutical, Inc.   announced that the U.S. Food and Drug Administration ...
Monday, September 12, 2016

Exelixis Announces FDA Approval of Cabometyx (cabozantinib) for Patients with Advanced Renal Cell Carcinoma

›
In continuation of my update on   cabozantinib Exelixis, Inc.   announced that the U.S. Food and Drug Administration (FDA) h...
Thursday, September 8, 2016

Bevespi Aerosphere Approved by the FDA for Patients with COPD

›
In continuation of my update on  Formoterol   Formoterol       glycopyrrolate AstraZeneca announced that the US Food and Drug Admini...